Philips announces European availability of innovations to advance personalized and efficient cardiac care at EuroPCR 2021
18 mai 2021 04h00 HE | Royal Philips
May 18, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique...
Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and patient focus during image-guided procedures at ACC.21
14 mai 2021 04h00 HE | Royal Philips
May 14, 2021 Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Amsterdam, the Netherlands –...
Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035” low-dose Drug-Coated Balloon
20 avr. 2021 11h25 HE | Royal Philips
April 20, 2021 Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal...
Philips installs leading digital imaging solutions at new Central Acute Services Building of Westmead Hospital in Sydney Australia
19 avr. 2021 04h00 HE | Royal Philips
April 19, 2021 New state-of-the-art Central Acute Services Building at Westmead Hospital features next-generation diagnostic and neurovascular imaging solutions, aimed at improving the efficiency...
Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance
06 avr. 2021 09h00 HE | Royal Philips
April 6, 2021 Intuitive, table-side touchscreen control offers interventionalists enhanced diagnostic confidence and streamlined workflows [1]Full control of image acquisition and analysis from...
Philips introduces ClarifEye Augmented Reality Surgical Navigation to advance minimally-invasive spine procedures
02 févr. 2021 04h00 HE | Royal Philips
February 2, 2021 Industry-first image-guided therapy solution combines imaging and augmented reality navigation into one system in the Hybrid Operating RoomUnique 3D visualization technology –...
Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
25 janv. 2021 07h35 HE | Royal Philips
January 25, 2021 Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with...
Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics
25 janv. 2021 04h00 HE | Royal Philips
January 25, 2021 5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing solutions, and minimally-invasive intervention technology to deliver faster and...
Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
07 nov. 2020 11h15 HE | Royal Philips
November 07, 2020 Meta-analysis of two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and...
DEFINE PCI study one-year data show potential of treating residual ischemia to improve clinical outcomes for coronary stent patients
15 oct. 2020 13h00 HE | Royal Philips
October 15, 2020 New data suggest that PCI guided by iFR co-registered on the angiogram can improve outcomes and reduce angina for patients more effectively than treatment guided by angiography...